Sara Paradinas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sara Paradinas has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Orfao
Departamento de Medicina y Servicio de Citometría (NUCLEUS) Centro de Investigación del Cáncer (IBMCC Instituto de Investigación Biosanitaria de Salamanca (IBSAL) CSIC/USAL) Universidad de Salamanca Salamanca
1 shared publication - Manuel Fuentes
University of Salamanca (Universidad de Salamanca)
1 shared publication - María González-González
Department of Medicine and General Cytometry Service-Nucleus, CIBERONC ISCIII, Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain
1 shared publication - Noelia Dasilva
Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain
1 shared publication - Paula Díez
Department of Immunology, Leiden University Medical Center (LUMC), Leiden, The Netherlands
1 shared publication - Sergio Matarraz
Cytometry Service (NUCLEUS), and IBSAL. Cancer Research Center (IBMCC, University of Salamanca-CSIC), Salamanca, Spain
1 shared publication
Latest Publications
- Open Access
Biomarker Discovery by Novel Sensors Based on Nanoproteomics Approaches
During the last years, proteomics has facilitated biomarker discovery by coupling high-throughput techniques with novel nanosensors. In the present review, we focus on the study of label-based and label-free detection systems, as well as nanotechnology approaches, indicating their advantages and applications in biomarker discovery. In addition, several disease biomarkers are shown in order to display the clinical importance of the improvement of sensitivity and selectivity by using nanoproteomics approaches as novel sensors.
Open AccessBiomarker Discovery by Novel Sensors Based on Nanoproteomics Approaches
During the last years, proteomics has facilitated biomarker discovery by coupling high-throughput techniques with novel nanosensors. In the present review, we focus on the study of label-based and label-free detection systems, as well as nanotechnology approaches, indicating their advantages and applications in biomarker discovery. In addition, several disease biomarkers are shown in order to display the clinical importance of the improvement of sensitivity and selectivity by using nanoproteomics approaches as novel sensors.